| 2026-03-31 |
详情>>
股本变动：
变动后总股本124.08万股
|
| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益-8.93美元,归母净利润-702.74万美元,同比去年增长38.93%
|
| 2026-03-25 |
复牌提示：
2026-03-25 07:55:00 停牌，复牌日期 2026-03-25 08:30:00
|
| 2026-03-02 |
详情>>
内部人交易：
Tokman Alexander Y等共交易2笔
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-5.68美元,归母净利润-385.82万美元,同比去年增长47.57%
|
| 2025-10-28 |
股东大会：
将于2025-12-09召开股东大会
会议内容 ▼▲
- 1.To elect the four director nominees named in the enclosed proxy statement for election as directors of the Company to serve one-year terms expiring at the 2026 annual meeting of stockholders (each to serve until their successors are duly elected and qualified or until their earlier death, resignation, or removal).
2.To hold an advisory vote on executive compensation.
3.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2025.
4.To approve an amendment to our Certificate of Incorporation increasing the number of authorized shares of common stock from 20,000,000 shares to 1,000,000,000 shares.
5.To approve an amendment to our Certificate of Incorporation to exculpate certain of our officers as permitted by recent changes to Delaware law.
6.To approve a second amendment to our 2016 Omnibus Incentive Plan.
7.To transact such other business as may properly come before the 2025 Annual Meeting.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-3.55美元,归母净利润-226.22万美元,同比去年增长54.80%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-1.86美元,归母净利润-103.63万美元,同比去年增长62.66%
|
| 2025-04-07 |
详情>>
业绩披露：
2024年年报每股收益-56.94美元,归母净利润-1150.79万美元,同比去年增长-14.39%
|
| 2024-11-21 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-82.14美元,归母净利润-735.89万美元,同比去年增长14.44%
|
| 2024-11-05 |
详情>>
拆分方案：
每35.0000合并分成1.0000股
|
| 2024-09-16 |
股东大会：
将于2024-10-28召开股东大会
会议内容 ▼▲
- 1.To approve amendments to our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation” or “Charter”) effecting reverse stock splits of our common stock at ratios between 1-for-4 and 1-for-35, inclusive, one of which reverse stock split ratios will be chosen, at the discretion of our Board of Directors on or prior to the one-year anniversary of the date of the Special Meeting, and the remainder of which reverse stock split ratios will be abandoned.
2.To transact such other business as may properly come before the Special Meeting and any adjournments or postponements thereof.
|
| 2024-08-20 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.26美元,归母净利润-500.49万美元,同比去年增长9.00%
|
| 2024-08-14 |
财报披露：
美东时间 2024-08-14 盘后发布财报
|
| 2024-06-25 |
股东大会：
将于2024-08-06召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To hold an advisory vote on executive compensation.
3.To hold a vote to authorize the issuance of shares of Common Stock upon the exercise of certain warrants sold in our recent public offering, and approve certain adjustment provisions included in such warrants.
4.To hold a vote on the approval of an amendment to our Certificate of Incorporation increasing the number of authorized shares of Common Stock from 80,000,000 shares to 1,000,000,000 shares.
5.To hold a vote on the approval of an amendment to our Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of our Common Stock at a stock split ratio between 1-for-20 and 1-for-50, inclusive, with the ultimate ratio to be determined by the Board of Directors in its sole discretion.
6.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2024.
7.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.26美元,归母净利润-277.57万美元,同比去年增长5.68%
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益-1.58美元,归母净利润-1006.02万美元,同比去年增长23.67%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.53美元,归母净利润-860.07万美元,同比去年增长13.03%
|
| 2023-05-24 |
股东大会：
将于2023-07-06召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To hold an advisory vote on executive compensation.
3.To hold an advisory vote on frequency of future advisory votes on executive compensation.
4.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2023.
5.
|
| 2022-12-08 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2022-10-17 |
股东大会：
将于2022-11-29召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation” or “Charter”) to effect, at the discretion of our Board of Directors on or prior to the one-year anniversary of the date of the Special Meeting, a reverse stock split of our common stock at a stock split ratio between 1-for-2 and 1-for-30, with the ultimate ratio to be determined by the Board of Directors in its sole discretion (the “Reverse Stock Split”), the implementation and timing of which shall be subject to the discretion of the Board of Directors.
2.To transact such other business as may properly come before the Special Meeting and any adjournments or postponements thereof.
|
| 2022-05-02 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To approve an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 80,000,000 shares to 130,000,000 shares.
3.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2022.
4.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2021.
3.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-16召开股东大会
会议内容 ▼▲
- 1.To elect the six nominees to the Board of Directors nominated by the Board of Directors.
2.To approve an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 50,000,000 shares to 80,000,000 shares.
3.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2020.
4.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|
| 2019-04-15 |
股东大会：
将于2019-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2019.
3.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|
| 2018-05-10 |
股东大会：
将于2018-06-12召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees to the Board of Directors nominated by the Board of Directors.
2.To approve the First Amendment to the ENDRA Life Sciences Inc. 2016 Omnibus Incentive Plan, which would, among other things, provide for an automatic annual increase to the pool of shares available for issuance each January 1 beginning in 2019 by an amount equal to the lesser of (i) the number of shares necessary such that the aggregate number of shares available under the plan equals 25% of the number of fully-diluted outstanding shares on the increase date (assuming the conversion of all outstanding shares of preferred stock and other outstanding convertible securities and exercise of all outstanding options and warrants to purchase shares) and (ii) if the Board of Directors takes action to set a lower amount, the amount determined by the Board of Directors.
3.To ratify the appointment of RBSM LLP as our independent registered public accounting firm for 2018.
4.To transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
|